Dorota Kakol‐Palm

An oral antisense oligonucleotide for PCSK9 inhibition

Peter Gennemark, Katrin Walter, Niclas Clemmensen et al. · Science Translational Medicine · 2021 · 121 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

<i>PCSK9</i> rs11591147 R46L loss‐of‐function variant protects against liver damage in individuals with NAFLD

Stefania Grimaudo, Stefano Bartesaghi, Raffaela Rametta et al. · Liver International · 2020 · 57 citations

Medicine, Molecular Genetics, Pharmacology +17

Effects of a novel potent melanin‐concentrating hormone receptor 1 antagonist, AZD1979, on body weight homeostasis in mice and dogs

Karolina Ploj, Lambertus Benthem, Dorota Kakol‐Palm et al. · British Journal of Pharmacology · 2016 · 34 citations · Full text

Medicine, Endocrinology, Pharmacology +17

GPR103 Antagonists Demonstrating Anorexigenic Activity in Vivo: Design and Development of Pyrrolo[2,3-<i>c</i>]pyridines That Mimic the C-Terminal Arg-Phe Motif of QRFP26

Jennie Georgsson, Fredrik Bergström, Anneli Nordqvist et al. · Journal of Medicinal Chemistry · 2014 · 24 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

A modeling approach for compounds affecting body composition

Peter Gennemark, Rasmus Jansson‐Löfmark, Gina Hyberg et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2013 · 19 citations

Pharmacy, Nutritional Sciences, Human Nutrition +9